Navigation Links
Study examining role of genetics and environment in type 1 diabetes
Date:2/25/2009

ing they can to help us find a cure for diabetes."

One in 200 children in the U.S. develop type 1 diabetes, an incidence rate that is increasing 3 to 5 percent each year, researchers say. Although TEDDY screens for just two, about a dozen genes are now known to increase risk. Drs. She and Cong-Yi Wang discovered one of those genes, SUMO-4, in 2004 and will soon publish findings about another. When more comprehensive genetic screening is available Dr. She thinks there are at least 20 genes it should be about 50 percent accurate at identifying children who will develop the disease, he says.

Dr. She's studies are yielding protein markers that indicate there are actually subtypes of type 1 diabetes, which fits with the large number of genes and apparent environmental factors that seem to come into play. "You are probably not going to stop the disease in all children with one approach." Rather he hopes TEDDY will help researchers identify child-specific causes so an individualized treatment or even prevention strategy can be identified.

"We want to identify the environmental factors, we can't do anything yet about the genetic factors," says Diane Hopkins, project manager. "We think high-risk children are exposed to a set of triggers, it may be dietary, it may be viral, it may be a stressor, it may be all three. It could be viral but only if the exposure occurs early in life. It may be different things in different people. It's anybody's guess at this point."

For example, a prevailing theory is that early exposure to cow's milk is a cause and breast feeding is protective. So TEDDY is gathering data about what kind of milk or formula the child gets. "There is a ton of information we are collecting," Mrs. Hopkins says. A goal of TEDDY is to discern fact from theory then work backward to fight the disease. Researchers hope one day the screening they provide will be routine and that when high-risk genes surface, parents can receive an i
'/>"/>

Contact: Toni Baker
tbaker@mcg.edu
706-721-4421
Medical College of Georgia
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Childhood obesity indicates greater risk of school absenteeism, Penn study reveals
2. A study by the MUHC and McGill University opens a new door to understanding cancer
3. Study begins to reveal clues to the cause and progression of sepsis
4. Clones on task serve greater good, evolutionary study shows
5. New study warns limited carbon market puts 20 percent of tropical forest at risk
6. New study examines how rearing environment can alter navigation
7. Study links cat disease to flame retardants in furniture and to pet food
8. New continent and species discovered in Atlantic study
9. Study shows link between alcohol consumption and hiv disease progression
10. Feeling hot, hot, hot: New study suggests ways to control fever-induced seizures
11. Study finds environmental tests help predict hospital-acquired Legionnaires disease risk
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study examining role of genetics and environment in type 1 diabetes
(Date:7/21/2015)... Today, ZTE announced its Android smartphone Axon, featuring FPC,s touch ... 2015 that relate to sales of FPC1025 for this smartphone model ... for 2015. Jörgen Lantto, CEO of FPC, comments: " ... China and we are proud that ZTE ... Axon , its first smartphone ...
(Date:7/13/2015)... Jul. 13, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce ... patent 62/188684 for BEHAVIORAL-DIRECTED AUTHENTIATION METHOD ... convenient and secure method to make payments.  With ... methods, introduced with its groundbreaking voice-direct payment patent ...
(Date:7/8/2015)... 8, 2015 Summary Pancreatic cancer is ... most fatal, with a mortality rate of 10.9 deaths ... pancreatic cancer patients has highlighted a significant need for ... being met by the current market. A highly ... with varying molecule types and mechanisms of action, which ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3
... people are injured or die each year in hospitals ... hospital, depending on its size, about US$5.6 million every ... the personal costs of injuries to patients. , Nationally, ... hospital admission are enormous: between $1.6 billion and $5.6 ...
... designated a group of 13 tropical ... African Sleeping Sickness (African trypanosomiasis), Chagas ... (elephantiasis), Onchocerciasis (river blindness), Drancunculiasis (guinea ... Trachoma). , These diseases have much ...
... production of a protein called vasostatin may prove a promising ... of print in Gut. , Pancreatic cancer is the fifth ... is extremely difficult to treat. Only 3% of affected patients ... that has remained static for the past three decades. , ...
Cached Biology News:Is it Possible to Change Prescribing Habits? 2Is it Possible to Change Prescribing Habits? 3A New Era of Hope for the World's Most Neglected Diseases 2A New Era of Hope for the World's Most Neglected Diseases 3Gene therapy potential for treatment of pancreatic cancer 2
(Date:7/29/2015)... ... July 29, 2015 , ... Asymmetrex, LLC ... progress in evaluating the full range of capabilities of its unique cache of ... cells perform the day-to-day renewal and repair of normal tissues and organs. This ...
(Date:7/28/2015)... July 28, 2015  PDL BioPharma, Inc. (PDL, or ... the Company will release its second quarter 2015 financial ... Wednesday, August 5, 2015, after market close. PDL,s management ... at 4:30 p.m. Eastern Time to discuss the financial ... be available via the webcast link on the PDL ...
(Date:7/28/2015)... 21, 2015 Research and Markets ( ... "Biomedical Refrigerators and Freezers Market - Global ... 2014 - 2022" report to their offering. ... freezers market has been segmented based on applications: ... and others. The others segment includes applications of ...
(Date:7/28/2015)... , July 28, 2015  Moerae Matrix Inc. ... 1 clinical trial with MMI-0100, a first-in-class inhibitor ... developed for pulmonary disorders characterized by inflammation and ... United Kingdom , is a double-blind, two-way ... the safety and tolerability of MMI-0100 when given ...
Breaking Biology Technology:Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 2Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 3Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 4PDL BioPharma to Announce Second Quarter 2015 Financial Results on August 5, 2015 2Biomedical Refrigerators and Freezers Market Report - Global Industry Analysis 2015 2Biomedical Refrigerators and Freezers Market Report - Global Industry Analysis 2015 3Moerae Initiates Lipopolysaccharide (LPS) Challenge Study of Inhaled MMI-0100 for Pulmonary Disease Following Encouraging Safety and Tolerability Observed in Single Ascending Dose Phase 1 Study 2
... , ... Specialist Segmentation Module explores how oncologists use the Internet and other technologies for professional ... ... than the overall population of U.S. physicians to visit pharmaceutical, biotech, and device corporate ...
... , , , PHILADELPHIA, ... technologies for biomedical research, molecular diagnostics and personalized medicine, today ... have joined the company,s advisory team. Dr. Lee is ... at Brigham and Women,s Hospital, Harvard Medical School and the ...
... HOERSHOLM, Denmark and SAN DIEGO, California, September 16 /PRNewswire/,-- , ... Leading RNA Industry Expert,Art Levin Ph.D. as President of US ... - Utilizing its Proprietary RNA Chemistry - Locked Nucleic Acid ... Relationships,With New Partners, Increase Visibility With Capital Markets and Attract,Leading ...
Cached Biology Technology:Oncologists Visit Pharma Sites and Post Professional Content Online More Frequently than the Average Physician 2Oncologists Visit Pharma Sites and Post Professional Content Online More Frequently than the Average Physician 3Oncologists Visit Pharma Sites and Post Professional Content Online More Frequently than the Average Physician 4BioNanomatrix Appoints Genomic Research Experts Charles Lee and David L. Barker as Advisers 2BioNanomatrix Appoints Genomic Research Experts Charles Lee and David L. Barker as Advisers 3BioNanomatrix Appoints Genomic Research Experts Charles Lee and David L. Barker as Advisers 4New Collaborations and Breakthrough Advancements in RNA-Based Drug Development Programs Lead Santaris Pharma A/S to Establish US Operations 2New Collaborations and Breakthrough Advancements in RNA-Based Drug Development Programs Lead Santaris Pharma A/S to Establish US Operations 3New Collaborations and Breakthrough Advancements in RNA-Based Drug Development Programs Lead Santaris Pharma A/S to Establish US Operations 4
... , Customer Peptide Synthesis , 20 Amino Acid length ... 20 mg will return to customer for future usage conjugation ... , Maintenance 102 days/each , ... x5 /each , Test bleed (app. 5 ml) ...
Request Info...
... This Kit Contains the following: , Coated Capture ... sealers , Wash/Sample Diluent: 300 mL of 2X ... vial 10 microg lyophilized peptide , Lyophilized Standard ... of 50X concentrate , Secondary Antibody-HRP: 30 microL ...
...
Biology Products: